All accepted abstracts are available in the Journal for ImmunoTherapy of Cancer (JITC).
Poster Presentation Dates
All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST. Even numbered posters will be presented on Thursday, Nov. 12, from 4:50-5:20 p.m. EST and Saturday, Nov. 14, from 1-1:30 p.m. EST.
Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.
|661||Poster Presentation||Five immunotypic signatures identified in human glioblastoma correlate with tumor contact with the lateral ventricle, immune suppression, and patient outcome.||Todd Bartkowiak, MS, PhD; Sierra M. Barone, BS; Madeline J. Hayes, BS; Allison R. Greenplate, Ph.D; Justine Sinnaeve, Ph.D.; Nalin Leelatian, M.D., Ph.D.; Akshitkumar M. Mistry, M.D.; Caroline E. Roe, MLS; Bret C. Mobley, M.D.; Lola B. Chambless, MD; Reid C. Thompson, M.D.; Kyle D. Weaver, M.D.; Rebecca A. Ihrie, Ph.D.; Jonathan M. Irish, Ph.D.; Todd Bartkowiak, MS, PhD;||Machine Learning, Artificial Intelligence, and Computational Modeling||Bioinformatics; Coinhibition; Cytokine; Immune contexture; Immune suppression; Myeloid cells; Solid tumors; Systems biology; Tumor infiltrating lymphocytes (TILs); Tumor microenvironment|